Activation of Melatonin Signaling Promotes β-Cell Survival and Function

Safia Costes, Marti Boss, Anthony P. Thomas, +1

Molecular Endocrinology

ApoptosisImmunologyImmune RegulationCell DeathMelatonin Signaling +18

Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis

Daphne N. Dorst, Mark Rijpkema, Marti Boss, +10

Lara D. Veeken

⁶⁸Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

Marti Boss, Christof Rottenburger, Winfried Brenner, +14

Journal of Nuclear Medicine

PET-Based Human Dosimetry of ⁶⁸Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging

Marti Boss, Mijke Buitinga, Theodorus J.P. Jansen, +3

Journal of Nuclear Medicine

Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients

Mijke Buitinga, Inge van der Kroon, Wietske Woliner-van der Weg, +8

Journal of Nuclear Medicine

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions

Marti Boss, Desirée L. Bos, Cathelijne Frielink, +6

Journal of Nuclear Medicine

Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [68Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method

Silvia Migliari, Antonino Sammartano, Marti Boss, +6

Molecules

Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development

Daphne N. Dorst, Marti Boss, Mark Rijpkema, +11

Pharmaceutics

68Ga-NODAGA-exendin-4 PET/CT for the localization of insulinomas

Marti Boss, Kirsi Mikkola, Mijke Buitinga, +7

Nuklearmedizin - NuclearMedicine

Improved LocalizationStable GlucagonEndocrine OncologyOncologic ImagingDiabetes +10

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW

Marti Boss, Desirée L. Bos, Cathelijne Frielink, +9

Journal of Nuclear Medicine